Capstone Investment Advisors, LLC Aclaris Therapeutics, Inc. Transaction History
Capstone Investment Advisors, LLC
- $38.9 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ACRS
# of Institutions
99Shares Held
80.7MCall Options Held
257KPut Options Held
92.3K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$33.2 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$22.4 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$20.7 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$14.5 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$10.9 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $155M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...